Setareh Seyedkazemi insider trades
Open-market stock purchases and sales by Setareh Seyedkazemi, CHIEF DEVELOPMENT OFFICER at Adverum Biotechnologies, Inc, from SEC Form 4 filings since Jan 6, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Bought (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $406K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $431K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $86.2K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $188K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $311K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $205K |
Companies traded
- ADVM Adverum Biotechnologies, Inc: 1 buy, 4 sales, last Dec 9, 2025
Get free alerts when Setareh Seyedkazemi files a new trade →